DIA 2013 49th Annual Meeting
Click here to go to the previous page
Molecular Imaging: Utilizing It as an Effective Drug Development Tool
Track
:
Track 04: Nonclinical and Translational Development/Early Phase Clinical Development
Program Code:
306
Date:
Wednesday, June 26, 2013
Time:
8:00 AM to 9:30 AM
EST
Location:
105
CHAIR
:
Todd E. Peterson, PhD (SCHSUP), Director, Nuclear Imaging; Associate Prof., Radiology and Radiological Sciences, Vanderbilt University, United States
SPEAKER
(S):
Jonathan McConathy, MD,PhD (SPKSUP), Assistant Professor of Radiology, Department of Radiology, Washington University, United States Todd E. Peterson, PhD (SPKSUP), Director, Nuclear Imaging; Associate Prof., Radiology and Radiological Sciences, Vanderbilt University, United States Jeffrey T. Yap, PhD (SPKSUP), Senior Diagnostic Physicist, Dana-Farber Cancer Institute, United States
Description
Molecular imaging (MI) can assist in the development of new drugs. It can provide MI biomarkers that can be utilized in trials as endpoints for clinical outcomes. In this session, we will discuss the development of MI biomarkers and their use in drug development.
This session is a part of:
This session is a part of: